Terug
29
Dagbereik
€ 2,19
€ 2,19
52-Weeksbereik
€ 2,14
€ 3,30
Volume
100
50D / 200D Gem.
€ 2,70
/
€ 2,73
Vorige Slotkoers
€ 2,19
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 32,1 | 0,4 |
| P/B | 3,2 | 2,9 |
| ROE % | 10,6 | 3,8 |
| Net Margin % | 10,4 | 3,9 |
| Rev Growth 5Y % | 18,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Belangrijkste Punten
Revenue grew 18,22% annually over 5 years — strong growth
Earnings grew 59,39% over the past year
ROE of 10,55% — decent returns on equity
Debt/Equity of 0,04 — conservative balance sheet
Generating 35,26M in free cash flow
P/E of 32,13 — premium valuation
Groei
Revenue Growth (5Y)
18,22%
Revenue (1Y)17,01%
Earnings (1Y)59,39%
FCF Growth (3Y)33,64%
Kwaliteit
Return on Equity
10,55%
ROIC3,08%
Net Margin10,39%
Op. Margin4,49%
Veiligheid
Debt / Equity
0,04
Current Ratio5,66
Interest Coverage6,10
Waardering
P/E Ratio
32,13
P/B Ratio3,16
EV/EBITDA57,22
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,01% | Revenue Growth (3Y) | 8,97% |
| Earnings Growth (1Y) | 59,39% | Earnings Growth (3Y) | 1,97% |
| Revenue Growth (5Y) | 18,22% | Earnings Growth (5Y) | 24,60% |
| Profitability | |||
| Revenue (TTM) | 198,93M | Net Income (TTM) | 20,68M |
| ROE | 10,55% | ROA | 7,59% |
| Gross Margin | 78,25% | Operating Margin | 4,49% |
| Net Margin | 10,39% | Free Cash Flow (TTM) | 35,26M |
| ROIC | 3,08% | FCF Growth (3Y) | 33,64% |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 5,66 |
| Interest Coverage | 6,10 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 32,13 | P/B Ratio | 3,16 |
| P/S Ratio | 3,34 | PEG Ratio | 0,84 |
| EV/EBITDA | 57,22 | Dividend Yield | 0,00% |
| Market Cap | 664,33M | Enterprise Value | 510,72M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 198,93M | 170,01M | 167,52M | 119,73M | 101,83M |
| Net Income | 20,68M | 12,97M | 19,88M | 3,74M | 8,58M |
| EPS (Diluted) | 0,07 | 0,04 | 0,06 | 0,01 | 0,03 |
| Gross Profit | 155,66M | 132,44M | 125,66M | 86,15M | 74,91M |
| Operating Income | 8,93M | 9,12M | 18,00M | 792.000,0 | 8,38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 272,48M | 237,34M | 226,08M | 193,24M | 164,58M |
| Total Liabilities | 62,57M | 55,14M | 62,22M | 54,55M | 29,01M |
| Shareholders' Equity | 209,91M | 182,20M | 163,86M | 138,69M | 135,57M |
| Total Debt | 7,69M | 9,30M | 10,72M | 11,71M | 2,49M |
| Cash & Equivalents | 161,29M | 129,55M | 112,16M | 94,51M | 96,03M |
| Current Assets | 225,32M | 198,45M | 181,24M | 150,50M | 142,15M |
| Current Liabilities | 39,79M | 32,23M | 33,03M | 28,64M | 19,54M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#840 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026